Supplementary Table S1 from ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer
Abstract
Top 30 significantly upregulated and downregulated differentially expressed genes in MM468/AR cells compared to parental cells
Fields of Study & Subjects
Breast Cancer Treatment Studies
Prostate Cancer Treatment and Research
Estrogen and related hormone effects
Publication details
- Publication date
- 27 February 2026
- Language
- EN